Z. Diamant (Leiden, Netherlands), D. Spina (London, United Kingdom)
Management of bronchial asthma during pregnancy
L. Tamasi, A. Bohacs, J. Rigo Jr, P. Magyar, G. Losonczy (Budapest, Hungary)
|  |
Comparative characteristics of inflammatory markers depending on treatment approaches in brittle asthma
L. M. Ogorodova, O. S. Kobyakova, A. E. Sazonov, T. S. Smetanenko (Tomsk, Russian Federation)
| |
Analysis of pre-hospital management in hospitalized patients with bronchial asthma (BA) exacerbation: 6-year observational study
P. V. Sereda, V. I. Aksenov (St. Petersburg, Russian Federation; Gainesville, United States Of America)
| |
The way to improve the steroid sensitivity of target cells of patients with severe therapy resistant asthma
L. N. Sorokina, V. N. Mineev, A. A. Bibkova (Saint Petersburg, Russian Federation)
| |
A comparison of fluticasone propionate (FP) and mometasone furoate (MF) nasal spray in the treatment of nasal polyposis associated with asthma
M. D. Filipovic, S. S. Cekic (Nis, Serbia And Montenegro)
| |
Bronchodilator responses of a cup of tea in asthmatic subjects
B. B. Brashier, J. S. Mandale, V. Vincent, A. Raghupati, S. D. Valsa, S. S. Salvi (Pune, India)
| |
The management of acute asthma with and without the administration of aminophylline
G. Pavlakou, D. Antoniou, D. Hatjilia, E. Tsaroucha, O. Anagnostopoulou (Athens, Greece)
| |
Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients
M. Jakopovic, F. Pavicic, M. Samarzija, G. Redzepi, N. Tudoric, Z. Vrbica, S. Grle-Popovic (Zagreb, Dubrovnik, Croatia)
| |
Incidence of oral candidiasis during treatmet with fluticasone propionate versus beclomethasone dipropionate
D. Todevski, A. Gjorcev, M. Zdraveska, D. Dimitrievska, S. Stojkovski, O. Jovkovski (Skopje, Fyrom)
| |
A new treatment (Passion fruit) for asthma
J. Ghaffari, Z. Nazari, R. Farid, F. Jabbari, H. Rafatpanah (Sari, Mashhad, Islamic Republic Of Iran)
| |
Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials
T. Macioch, M. Niewada, M. Wlodarczyk, K. A. Wardyn (Warsaw, Poland)
| |
Clinical effectiveness of MDI-HFA-Modulite beclomethasone in the treatment of asthma – meta-analysis of randomized controlled trials
T. Macioch, M. Niewada, M. Wlodarczyk, K. A. Wardyn (Warsaw, Poland)
| |
Noneosinophilic asthma: persistence over time and effect of treatment
E. Bacci, M. L. Bartoli, F. Costa, F. L. Dente, E. Garbella, E. Polverino, M. De Santis, P. L. Paggiaro (Pisa, Italy)
| |
Perceived bronchodilator efficacy during severe asthma exacerbations
H. K. Reddel, C. R. Jenkins, P. G. Gibson, S. D. Vincent (Camperdown, New Lambton, Australia)
| |
Anti-inflammatory effect and clinical efficacy of concomitant treatments to steroid inhaler in bronchial asthma: montelukast versus salmeterol
T. Shimoda, R. Kishikawa, S. Shoji, S. Nishima (Fukuoka, Japan)
| |
Tolerability of high cumulative doses of a new fixed combination of beclomethasone dipropionate/formoterol in asthmatic patients
A. Piccinno, Z. Borrill, G. Poli, D. Acerbi, D. Singh, L. Meuleners, A. Woodcock (Parma, Italy; Manchester, United Kingdom; Mechelen, Belgium)
| |
Clinical efficacy of new non-freon aerosol troventol in asthma patients
T. L. Pashkova, S. Y. Chikina, A. V. Cherniak, Z. K. Naumenko, G. V. Nekludova, G. Y. Shvarts, A. G. Chuchalin (Moscow, Russian Federation)
| |
Effect of omeprazol on pulmonary function test in asthmatic patients
F. Mansouri, E. N. Khorasani (Kermanshah, Tehran, Islamic Republic Of Iran)
| |
Bronchial asthma as neurogenic inflammatory and paroxysmal disease – efficacy of antiepileptic drug diphenine in asthma therapy
M. Lomia, M. Pruidze, C. Zaza, T. Tamara (Tbilisi, Georgia)
| |
Effects of zileuton on leukotriene formation in human blood cells and expression of enzymes in the biosynthetic pathway
F. Gaber, A. James, I. Delin, A. P. Sampson, B. Dahlén, S. E. Dahlén, M. Kumlin (Stockholm, Sweden; Southampton, United Kingdom)
| |